A descriptive study of the single-nucleotide polymorphisms known to affect the Tacrolimus trough concentration per dose, among a population of kidney failure patients in a tertiary hospital in Ghana
Abstract Background The burden of chronic kidney disease (CKD) and kidney failure in Ghana is on the ascendency, with the prevalence of CKD estimated at 13.3%. Patients with CKD who progress to kidney failure require life sustaining kidney replacement therapy (KRT) which is almost exclusively availa...
Main Authors: | Edward Kwakyi, Edmund Tetteh Nartey, Michael Kobina Otabil, Isaac Asiedu-Gyekye, Samuel Yao Ahorhorlu, Vincent Bioma, William Kudzi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-07-01
|
Series: | BMC Research Notes |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13104-024-06868-8 |
Similar Items
-
Pharmacogenomic Analysis of CYP3A5*3 and Tacrolimus Trough Concentrations in Vietnamese Renal Transplant Outcomes
by: Nguyen TVA, et al.
Published: (2024-02-01) -
Induction of CYP3A activity by dexamethasone may not be strong, even at high doses: insights from a case of tacrolimus co-administration
by: Yoshiyuki Ohno, et al.
Published: (2023-12-01) -
Genetic factors underlying tacrolimus intolerance after liver transplantation
by: Yuan Liu, et al.
Published: (2022-09-01) -
Frequency of CYP3A5 Genetic Polymorphisms and Tacrolimus Pharmacokinetics in Pediatric Liver Transplantation
by: Jefferson Antonio Buendía, et al.
Published: (2020-09-01) -
Effects of CYP3A4*22 polymorphism on trough concentration of tacrolimus in kidney transplantation: a systematic review and meta-analysis
by: Jung Sun Kim, et al.
Published: (2023-07-01)